Chr19q13.41 microRNA cluster (C19MC); microRNA-517c (miR-517c); miR-520g BriefCommunication Pages: 5 - 5
Mammalian target of rapamycin (mTOR; FRAP; RAFT1); phosphoinositide 3-kinase (PI3K) BriefCommunication Pages: 7 - 7
MicroRNA-221 (miR-221); miR-222; phosphatase and tensin homolog deleted on chromosome ten (PTEN; MMAC1; TEP1); tissue inhibitor of metalloproteinases 3 (TIMP3); tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) BriefCommunication Pages: 10 - 10
Insulin-like growth factor-1 (IGF1; IGF-1); IGF-1 receptor (IGF1R; CD221) BriefCommunication Pages: 19 - 19
Suppressor of cytokine signaling 3 (SOCS3); ciliary neurotrophic factor (CNTF) BriefCommunication Pages: 21 - 21
Hypoxia-inducible factor (HIF); HIF prolyl hydroxylase (HIF-PH; EGLN) BriefCommunication Pages: 24 - 24
Integrated framework for identification of dysregulated pathways in cancer BriefCommunication Pages: 25 - 25
Cationic spermine-conjugated small interfering RNA for intracellular delivery of therapeutic siRNA BriefCommunication Pages: 28 - 28
Nanocarriers for brain tumor–specific delivery of small interfering RNA BriefCommunication Pages: 29 - 29
Prodrug approach to improving bioavailability of guanidino-containing compounds BriefCommunication Pages: 30 - 30
Nonglycosylated Fc γ-receptor I (CD64; FCGR1)-selective IgG antibodies BriefCommunication Pages: 32 - 32
Microfluidics-based cell sorting for diagnostic platforms or sensors BriefCommunication Pages: 33 - 33